Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barth

Showing results (291-300 of 400) with videos related to

Pageof 40
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 8, 2014
Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomasRolf F Barth, George W Kabalka, Weilian Yang, et al.
Cancer Research|November 20, 2002
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomasWeilian Yang, Rolf F Barth, Dianne M Adams, et al.
Pharmaceutical Research|November 12, 2002
Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapyJennifer J Sudimack, Dianne Adams, Joan Rotaru, et al.
FEBS Letters|August 22, 1994
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorM Rinaldi-Carmona, F Barth, M Héaulme, et al.
Neurosurgery|September 1, 1990
Inhibition of tumor growth in a glioma model treated with boron neutron capture therapyJ H Goodman, J M McGregor, N R Clendenon, et al.
Life Sciences|January 1, 1996
Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainM Rinaldi-Carmona, F Pialot, C Congy, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonistM Portier, M Rinaldi-Carmona, F Pecceu, et al.
Cytogenetic and Genome Research|February 7, 2008
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphomaA Mader, S Bruderlein, S Wegener, et al.
Nuclear Medicine and Biology|January 11, 2001
Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptorsW B Mathews, U Scheffel, P Finley, et al.
The Journal of Rheumatology|June 1, 1993
Central nervous system herpesvirus infection in systemic lupus erythematosus: diagnosis by endoretinal biopsyM C Feinman, M A Friedberg, J C Schwartz, et al.
Pageof 40

Showing results (291-300 of 400) with videos related to

Sort By:
Pageof 40
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 8, 2014
Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomasRolf F Barth, George W Kabalka, Weilian Yang, et al.
Cancer Research|November 20, 2002
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomasWeilian Yang, Rolf F Barth, Dianne M Adams, et al.
Pharmaceutical Research|November 12, 2002
Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapyJennifer J Sudimack, Dianne Adams, Joan Rotaru, et al.
FEBS Letters|August 22, 1994
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorM Rinaldi-Carmona, F Barth, M Héaulme, et al.
Neurosurgery|September 1, 1990
Inhibition of tumor growth in a glioma model treated with boron neutron capture therapyJ H Goodman, J M McGregor, N R Clendenon, et al.
Life Sciences|January 1, 1996
Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainM Rinaldi-Carmona, F Pialot, C Congy, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonistM Portier, M Rinaldi-Carmona, F Pecceu, et al.
Cytogenetic and Genome Research|February 7, 2008
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphomaA Mader, S Bruderlein, S Wegener, et al.
Nuclear Medicine and Biology|January 11, 2001
Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptorsW B Mathews, U Scheffel, P Finley, et al.
The Journal of Rheumatology|June 1, 1993
Central nervous system herpesvirus infection in systemic lupus erythematosus: diagnosis by endoretinal biopsyM C Feinman, M A Friedberg, J C Schwartz, et al.
Pageof 40